All three teams of investigators also demonstrated that fecal transplantation of germ-free mice with feces from human responders (cancer patients) who participated in the aforementioned studies, but not from non-responders, significantly enhanced the efficacy of PD-1-directed immunotherapy in murine models of experimental tumorigenesis (82–84). This evidence concerns the gene PDCD1 and cancer.